CompletedNot applicableNCT03867461
The Effects of MAP and EtCO2 on Venous Sinus Pressures
Studying Idiopathic intracranial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wake Forest University Health Sciences
- Principal Investigator
- Kyle Fargen, MDWake Forest University Health Sciences
- Intervention
- Venous Sinus Stenting(procedure)
- Enrollment
- 8 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2019
Study locations (1)
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03867461 on ClinicalTrials.govOther trials for Idiopathic intracranial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06945848Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term AcetazolamideUniversity Hospital, Montpellier
- RECRUITINGNCT06950099Advanced Neuroimaging in Idiopathic Intracranial HypertensionThomas Jefferson University
- RECRUITINGNCT06855342Prospective Ocular Imaging for Intracranial Pressure EvaluationKing's College Hospital NHS Trust
- RECRUITINGPHASE2NCT06634069Study SOLACE SEPSISUniversity Hospital Pilsen
- ENROLLING BY INVITATIONNCT06581185Pseudotumor Cerebri Headache Ten Years OutcomeBnai Zion Medical Center
- RECRUITINGNCT06545981Ocular Perfusion in Patients With Idiopathic Intracranial HypertensionMedical University of Vienna
- RECRUITINGNANCT06059703Biomarkers in the Etiology of Idiopathic Intracranial HypertensionUniversity Hospital, Montpellier
- RECRUITINGNANCT07440277IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost EffectivenessUniversity of Birmingham